![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, May 09, 2006 5:33:07 PM
After listening to the conf.call I came away with the same take following the QandA as this ymb post. I was especially startled by the clumsiness with which the question regarding whether patients could switch medications was handled and the abruptness by the TRCA mgmt member when he cut off the guy struggling with the answer. For those of you that listened, what is your take on this, tia
UNANSWERED Questions fm CC
by: hardknox49
Long-Term Sentiment: Strong Buy 05/09/06 05:23 pm
Msg: 93809 of 93811
Here's a list of the Questions they did NOT answer when asked...please correct my notes if needed but that was worse than their last CC and one of the worst I've ever heard. Scientists should not be given a microphone...EVER!
1. Tom Schrader/Harris Nesbit wanted to know more about the 300 Identified patients...were they new or previously ID'd.
2. Chris Raynard(sp)/Robert Baird wanted an update on phase 3b for the expected enrollment and a timeline to which they replied "Things are fine and we're not prepared for specifics" and would not provide any update until 2Q.
3. Matt Osborne/Lazard asked them address 1)Off label uses and Rx and got no reply...2)Were there any promotions or free drugs to which they made him ask what did he mean and stated they did not "give any free drugs at the start of the launch" at which point that TRCA speaker was immediately interupted by another mgmt member who went off the subject!...3)What was the # of patients on at the end of the qtr and are there any paying customers yet. They stated that no enrolled patients have rolled over to paying customers.
4. SG Cowen rep asked how many committed of the 300 ID'd patients and could they switch medications midstream during treatment. This was amazing as there was literally 5 seconds of "Ah, Uh, Ah, Duh..." before someone cut off the stammerer and said and I quote " there are no guarentees" ... whatever that meant.
Recent INSM News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 12:00:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:21:15 PM
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • PR Newswire (US) • 06/07/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 08:23:25 PM
- Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference • PR Newswire (US) • 06/05/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:00:43 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2024 08:33:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 09:46:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 09:45:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 09:44:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 09:43:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 09:41:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 09:32:49 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/30/2024 08:15:33 PM
- Insmed to Host Commercial Webinar on June 4, 2024 • PR Newswire (US) • 05/30/2024 08:05:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/30/2024 08:02:27 PM
- Insmed Announces Pricing of $650 Million Public Offering of Common Stock • PR Newswire (US) • 05/30/2024 12:00:00 PM
- Insmed Announces Proposed $500 Million Public Offering of Common Stock • PR Newswire (US) • 05/28/2024 10:21:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/28/2024 08:51:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/28/2024 08:49:20 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/28/2024 08:47:36 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/28/2024 08:46:34 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/28/2024 08:40:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/28/2024 08:14:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 10:30:24 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM